Ron Menezes joined Sientra in November 2020 as President and Chief Executive Officer. Ron’s most recent experience includes serving as President and General Manager for Almirall U.S. – Dermatology, where he led exceptional growth and profitability improvements, returning the U.S. division to profitability. Ron was also part of the team that successfully acquired Allergan’s dermatology assets in 2018. In 2019, he led the launch of a new molecule for the treatment of acne that far exceeded revenue goals by strategically focusing on improving patients’ access to the product. Prior to Almirall, Ron was the Vice President of Sales and Marketing for Dermatology at Allergan, leading the team to more than 20% yearly growth between 2013 and 2015. The growth was driven by increased direct-to-consumer advertising and expanding the promotion of a 20-year-old topical product for acne. As a head of sales for SkinMedica, Latisse and Medical Dermatology, Ron was part of the commercial team that successfully launched a new direct-to-physician sunscreen product. While at SkinMedica, he focused on expanding national accounts that were responsible for driving most of the growth in 2015. Ron has also held key leadership responsibilities at Abbott, Astellas Pharma – U.S., Pfizer and Eli Lilly. Ron holds a B.S. in International Business from Brigham Young University and earned a certificate in Health Care Management from the University of Utah.

Dr. Denise Dajles joined Sientra in June 2021 as Vice President of Research and Development. Most recently, Denise served as Senior Director of Research, Development and Innovation leading the science and technology department at Establishment Labs. In this role, she was responsible for the successful execution of more than ten new product and technology projects, which includes several regulatory approvals for commercialization in the United States, Europe, Latin America and Asia Pacific, as well as for leading extensive scientific research. Previously, Denise was an advisor, investigator, and Interim Director in the Biomedical Engineering Lab at the University of Costa Rica School of Engineering. Denise holds both a Bachelor of Science and Master of Science in Biomedical Engineering from Washington University, St. Louis and a Doctorate in Engineering from The George Washington University, Washington, DC. She has co-authored several peer reviewed publications and is a named inventor on a number of technologies.

Andy Schmidt joined Sientra in July 2021. Andy brings to Sientra more than 20 years of financial leadership experience and has successfully directed the financial, M & A and capital market strategies of numerous publicly held companies. Most recently, he served as the CFO of Guardion Health Sciences, a Nasdaq-listed company focused on clinical nutrition, diagnostics, and medical devices. Previously, he served as the CFO of Iteris, Inc., a publicly traded global technology company. With a focus on internal and external strategic development and execution, Andy accelerated growth and achieved record stock performance. Prior, he was the CFO of publicly traded Smith Micro Software, Inc. and Genius Products, Inc. Earlier, he served in financial leadership roles with Peregrine Systems and Mad Catz Interactive. Andy received a Master of Science in Accountancy from San Diego State University and a Bachelor of Business Administration in Finance from the University of Texas, Austin, TX.

Adelle Walker joined Sientra in July 2023 as Senior Vice President, Corporate Strategy and Marketing. Adelle has a deep background in aesthetics, diagnostics, capital equipment, medical device, injectables and medically reimbursed specialty markets, responsible for leading the strategic and commercial execution plans with both new-to-market launches and on market high profile brands. Most recently, Adelle stood up a consumer products division at DermTech responsible for leading the development of D2C skin cancer DNA test division, where she launched a premarket disease awareness campaign delivering more than 12X the market impact growth. Prior to DermTech, Adelle lead a consulting business focused on market analysis and global product launches to physicians and consumers in both medical and aesthetic markets. Adelle also held the Chief Marketing Officer role at SENTE where she launched the physician dispensed skincare brand via e-commerce, returning the line to growth with an omni channel approach. At Candela, Adelle lead the build of the Global Marketing team in the US leading the growth of a large portfolio of laser systems which lead to the successful sale to Private Equity. Adelle also held key marketing leadership roles at Allergan over 13 years. She was the Head of Marketing for the Medical Dermatology Division and doubled the sales over three years through focusing on D2C and HCP pull through strategies. She also had other key Marketing Leadership roles at Allergan including heading up the aesthetic fillers group of Juvederm and leading a team of retail practice managers at SkinMedica.